Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/99443
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYelland, L.-
dc.contributor.authorMakrides, M.-
dc.contributor.authorMcPhee, A.-
dc.contributor.authorQuinlivan, J.-
dc.contributor.authorGibson, R.-
dc.date.issued2016-
dc.identifier.citationProstaglandins, Leukotrienes and Essential Fatty Acids, 2016; 107:8-11-
dc.identifier.issn0952-3278-
dc.identifier.issn1532-2823-
dc.identifier.urihttp://hdl.handle.net/2440/99443-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityLisa N. Yelland, Maria Makrides, Andrew J. McPhee, Julie Quinlivan, Robert A. Gibson-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2016 Elsevier Ltd. All rights reserved.-
dc.source.urihttp://dx.doi.org/10.1016/j.plefa.2016.02.003-
dc.subjectSample size-
dc.subjectlost to follow-up-
dc.subjectresearch design-
dc.subjectdocosahexaenoic acid-
dc.subjectpregnancy-
dc.titleImportance of adequate sample sizes in fatty acid intervention trials-
dc.typeJournal article-
dc.identifier.doi10.1016/j.plefa.2016.02.003-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/349301-
pubs.publication-statusPublished-
dc.identifier.orcidYelland, L. [0000-0003-3803-8728]-
dc.identifier.orcidMakrides, M. [0000-0003-3832-541X]-
dc.identifier.orcidMcPhee, A. [0000-0003-3820-5696]-
dc.identifier.orcidGibson, R. [0000-0002-8750-525X]-
Appears in Collections:Aurora harvest 7
Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_99443.pdfAccepted version545.14 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.